Comorbid infections in rheumatic diseases (according to FSBI RIR named after V.A. Nasonova)
Д. В. Буханова(Association of Rheumatologists of Russia), С. И. Глухова(Association of Rheumatologists of Russia), Б. С. Белов(Association of Rheumatologists of Russia), Г. М. Тарасова(Association of Rheumatologists of Russia), Т. В. Попкова, Yu. V. Muravyov(Association of Rheumatologists of Russia), L. P. Ananyeva(Association of Rheumatologists of Russia), S. K. Soloviev(Association of Rheumatologists of Russia), А. В. Гордеев(Association of Rheumatologists of Russia)
Cited by 14
Related Papers
RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES
|Rheumatology Science and Practice|2018|151
Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
|Rheumatology Science and Practice|2021|54
COVID-19: the new challenge for rheumatologists
|Modern Rheumatology Journal|2020|30
Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review
|Rheumatology Science and Practice|2021|14
Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues
|Rheumatology Science and Practice|2022|13